Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.

Acute Myeloid leukaemia AML is a fast-growing cancer of the bone marrow that disrupts blood cell production It differs from ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Scientists at St. Jude Children’s Research Hospital and University Health Network showed that the stage of B-cell development ...

Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...

A research team has discovered a previously unknown mechanism that could explain why many patients with aggressive B-cell lymphoma do not respond to CAR-T cell therapy in the long term. The results of ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Learn more about secondary acute myeloid leukemia, including what to expect after diagnosis, how to take care of yourself, and how to find support.

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

A young girl who captivated the hearts of Australians during her cancer battle has died years later after relapsing. Uma ...